» Articles » PMID: 21760991

Fluorescent Analysis of the Cell-selective Alzheimer's Disease Aβ Peptide Surface Membrane Binding: Influence of Membrane Components

Overview
Publisher Wiley
Date 2011 Jul 16
PMID 21760991
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

We performed a fluorescent analysis of the binding of Aβ to the surface membrane of different types of cells lines such as PC12, GT1-7, and ex vivo neurons. Analyses were performed on sorted cells with membrane bound Aβ Competitive binding between Aβ phosphatidyl serine- (PtdSer-) specific binder annexin V and an anti-PtdSer antibody provided compelling data confirming the involvement of PtdSer as one of the surface membrane signal molecules for Aβ. We found that populations of cells that exhibited high surface membrane binding affinity for Aβ also show higher membrane cholesterol levels compared to cells that did not bind Aβ. This direct relationship was upheld in cholesterol-enriched or cholesterol-depleted cell membranes. We conclude that the initial process for the cell-selective binding by Aβ, to later conversion of elemental Aβ units into larger structures such as fibrils or to the potentially toxic ion channel aggregates, is highly influenced by the membrane content of PtdSer and cholesterol in the cell surface membrane.

Citing Articles

Single-cell screening of cytosolic [Ca(2+)] reveals cell-selective action by the Alzheimer's Aβ peptide ion channel.

Lin H, Arispe N Cell Stress Chaperones. 2014; 20(2):333-42.

PMID: 25366568 PMC: 4326387. DOI: 10.1007/s12192-014-0551-2.


Coenzyme Q10 protects human endothelial cells from β-amyloid uptake and oxidative stress-induced injury.

Duran-Prado M, Frontinan J, Santiago-Mora R, Peinado J, Parrado-Fernandez C, Gomez-Almagro M PLoS One. 2014; 9(10):e109223.

PMID: 25272163 PMC: 4182835. DOI: 10.1371/journal.pone.0109223.


Cytotoxicity of intracellular aβ42 amyloid oligomers involves Ca2+ release from the endoplasmic reticulum by stimulated production of inositol trisphosphate.

Demuro A, Parker I J Neurosci. 2013; 33(9):3824-33.

PMID: 23447594 PMC: 3708452. DOI: 10.1523/JNEUROSCI.4367-12.2013.


Oxidative stress and β-amyloid protein in Alzheimer's disease.

Cai Z, Zhao B, Ratka A Neuromolecular Med. 2011; 13(4):223-50.

PMID: 21901428 DOI: 10.1007/s12017-011-8155-9.

References
1.
Simakova O, Arispe N . Early and late cytotoxic effects of external application of the Alzheimer's Abeta result from the initial formation and function of Abeta ion channels. Biochemistry. 2006; 45(18):5907-15. DOI: 10.1021/bi060148g. View

2.
Yanagisawa K . GM1 ganglioside and the seeding of amyloid in Alzheimer's disease: endogenous seed for Alzheimer amyloid. Neuroscientist. 2005; 11(3):250-60. DOI: 10.1177/1073858405275177. View

3.
Yankner B . Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron. 1996; 16(5):921-32. DOI: 10.1016/s0896-6273(00)80115-4. View

4.
Cecchi C, Rosati F, Pensalfini A, Formigli L, Nosi D, Liguri G . Seladin-1/DHCR24 protects neuroblastoma cells against Abeta toxicity by increasing membrane cholesterol content. J Cell Mol Med. 2008; 12(5B):1990-2002. PMC: 4506165. DOI: 10.1111/j.1582-4934.2008.00216.x. View

5.
Buchsteiner A, Hauss T, Dante S, Dencher N . Alzheimer's disease amyloid-beta peptide analogue alters the ps-dynamics of phospholipid membranes. Biochim Biophys Acta. 2010; 1798(10):1969-76. DOI: 10.1016/j.bbamem.2010.06.024. View